Articles From This Issue
Chief Medical Editor's Page
By Iqbal Ike K. Ahmed, MD, FRCSC
The path of innovation is not a straight line. It can certainly look that way in retrospect and from the outside. But those in the trenches learn that setbacks are a diff...
By Stephen Walters, MD; and Lama Al-Aswad, MD, MPH
Factors Associated With Health-Related Quality of Life in Medically and Surgically Treated Patients With Glaucoma...
By Jordan Stanley, MD; and Leonard K. Seibold, MD
Patients often ask, “Is there anything else I can do?”
Supplements and CME
CME - 1 Credit
New Treatments for Open-Angle Glaucoma and Ocular Hypertension: An Update on New Therapeutic Options (Part 1 of 2)
This educational activity was made possible in part by a grant from Bausch + Lomb.
Nathan Radcliffe, MD, Moderator; Ben Gaddie, OD; Louis Pasquale, MD
Sponsored by Quantel Medical
MARK LATINA, MD
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …